| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2016PLoSO..1151184B |
| P356 | DOI | 10.1371/JOURNAL.PONE.0151184 |
| P932 | PMC publication ID | 4786141 |
| P698 | PubMed publication ID | 26964063 |
| P5875 | ResearchGate publication ID | 297735131 |
| P50 | author | Teagan L Brown | Q59489885 |
| Zoe A Dyson | Q48060626 | ||
| P2093 | author name string | Joseph Tucci | |
| Robert Seviour | |||
| Steve Petrovski | |||
| P2860 | cites work | Acne vulgaris | Q54139548 |
| Antibiotic-resistant Propionibacterium acnes on the skin of patients with moderate to severe acne in Stockholm. | Q54382206 | ||
| Propionibacteria in patients with acne vulgaris and in healthy persons | Q72789325 | ||
| Topical treatment of Pseudomonas aeruginosa otitis of dogs with a bacteriophage mixture: a before/after clinical trial | Q84565387 | ||
| Lyophilized inserts for nasal administration harboring bacteriophage selective for Staphylococcus aureus: in vitro evaluation | Q84575997 | ||
| Acne vulgaris | Q95800673 | ||
| Propionibacterium acnes bacteriophages display limited genetic diversity and broad killing activity against bacterial skin isolates | Q36250598 | ||
| The role of Propionibacterium acnes in acne pathogenesis: facts and controversies | Q37677115 | ||
| Propionibacterium Levels In Patients With And Without Acne Vulgaris | Q39743579 | ||
| A novel multilocus sequence typing scheme for the opportunistic pathogen Propionibacterium acnes and characterization of type I cell surface-associated antigens. | Q39758237 | ||
| Genome sequence and characterization of the Tsukamurella bacteriophage TPA2 | Q39801755 | ||
| In vitro lung delivery of bacteriophages KS4-M and ΦKZ using dry powder inhalers for treatment of Burkholderia cepacia complex and Pseudomonas aeruginosa infections in cystic fibrosis | Q39833543 | ||
| Pros and cons of phage therapy | Q41083979 | ||
| Analysis of complete genomes of Propionibacterium acnes reveals a novel plasmid and increased pseudogenes in an acne associated strain | Q41142140 | ||
| Bacteriophages can treat and prevent Pseudomonas aeruginosa lung infections | Q43028377 | ||
| A novel sustained-release matrix based on biodegradable poly(ester amide)s and impregnated with bacteriophages and an antibiotic shows promise in management of infected venous stasis ulcers and other poorly healing wounds | Q44066581 | ||
| Organization and evolution of bacterial and bacteriophage primase-helicase systems | Q44080673 | ||
| A novel microgel complex delivers acne medicine deep into follicles while demonstrating high patient tolerance | Q48049106 | ||
| Bacteriophages, revitalized after 100 years in the shadow of antibiotics | Q48049505 | ||
| An examination of the mechanisms for stable foam formation in activated sludge systems | Q48060561 | ||
| Population genetic analysis of Propionibacterium acnes identifies a subpopulation and epidemic clones associated with acne | Q21089999 | ||
| A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa ; a preliminary report of efficacy | Q22061813 | ||
| The tRNAscan-SE, snoscan and snoGPS web servers for the detection of tRNAs and snoRNAs | Q24530279 | ||
| Bacteriophage therapy | Q24550616 | ||
| ARAGORN, a program to detect tRNA genes and tmRNA genes in nucleotide sequences | Q24634141 | ||
| Genome sequence and analysis of a Propionibacterium acnes bacteriophage | Q24678380 | ||
| Phage cocktails and the future of phage therapy | Q26995797 | ||
| The structure of bacteriophage T7 lysozyme, a zinc amidase and an inhibitor of T7 RNA polymerase | Q27731300 | ||
| Improved microbial gene identification with GLIMMER | Q27860463 | ||
| Pseudomonas aeruginosa keratitis in mice: effects of topical bacteriophage KPP12 administration | Q28484466 | ||
| AN INVESTIGATION ON THE NATURE OF ULTRA-MICROSCOPIC VIRUSES. | Q29039000 | ||
| Mauve: multiple alignment of conserved genomic sequence with rearrangements | Q29547292 | ||
| Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study | Q30692010 | ||
| Propionibacterium acnes types I and II represent phylogenetically distinct groups | Q33592477 | ||
| Characterization and genome sequencing of two Propionibacterium acnes phages displaying pseudolysogeny | Q33876889 | ||
| Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia | Q33938273 | ||
| A novel high-resolution single locus sequence typing scheme for mixed populations of Propionibacterium acnes in vivo. | Q34027565 | ||
| Treating acne with antibiotic-resistant bacterial colonization | Q34167188 | ||
| Propionibacterium acnes resistance: a worldwide problem | Q34175042 | ||
| Antibiotic-resistant acne: lessons from Europe | Q34185629 | ||
| The prospect for bacteriophage therapy in Western medicine | Q34201438 | ||
| Bacteriophage prevents destruction of skin grafts by Pseudomonas aeruginosa | Q34331837 | ||
| The complete genome sequence of Propionibacterium acnes, a commensal of human skin | Q34337656 | ||
| An expanded multilocus sequence typing scheme for propionibacterium acnes: investigation of 'pathogenic', 'commensal' and antibiotic resistant strains | Q34364135 | ||
| The use of a novel biodegradable preparation capable of the sustained release of bacteriophages and ciprofloxacin, in the complex treatment of multidrug-resistant Staphylococcus aureus-infected local radiation injuries caused by exposure to Sr90. | Q34386752 | ||
| Potential of bacteriophage ΦAB2 as an environmental biocontrol agent for the control of multidrug-resistant Acinetobacter baumannii | Q34802631 | ||
| Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial. | Q34996099 | ||
| The diversity and host interactions of Propionibacterium acnes bacteriophages on human skin | Q35596166 | ||
| Acne: topical treatment | Q35958847 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bacteriophage | Q165028 |
| Propionibacterium acnes | Q115483594 | ||
| P304 | page(s) | e0151184 | |
| P577 | publication date | 2016-03-10 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | The Formulation of Bacteriophage in a Semi Solid Preparation for Control of Propionibacterium acnes Growth | |
| P478 | volume | 11 |
| Q60920164 | Bacteriocins and Bacteriophages: Therapeutic Weapons for Gastrointestinal Diseases? |
| Q26738479 | Bacteriophage Procurement for Therapeutic Purposes |
| Q38776514 | Bacteriophage formulated into a range of semisolid and solid dosage forms maintain lytic capacity against isolated cutaneous and opportunistic oral bacteria. |
| Q41443659 | Characterization and formulation into solid dosage forms of a novel bacteriophage lytic against Klebsiella oxytoca |
| Q50421528 | Complete genomic sequences of Propionibacterium freudenreichii phages from Swiss cheese reveal greater diversity than Cutibacterium (formerly Propionibacterium) acnes phages |
| Q28069939 | Phage Therapy: Combating Infections with Potential for Evolving from Merely a Treatment for Complications to Targeting Diseases |
| Q47269772 | Phages of life - the path to pharma |
| Q90419978 | Propionibacterium (Cutibacterium) acnes Bacteriophage Therapy in Acne: Current Evidence and Future Perspectives |
| Q64890573 | Propionibacterium acnes and Acne Vulgaris: New Insights from the Integration of Population Genetic, Multi-Omic, Biochemical and Host-Microbe Studies. |
| Q37629864 | Prospects of Phage Application in the Treatment of Acne Caused by Propionibacterium acnes |
| Q55193419 | Semi-Solid and Solid Dosage Forms for the Delivery of Phage Therapy to Epithelia. |
| Q92826800 | The Perfect Bacteriophage for Therapeutic Applications-A Quick Guide |
| Q91730238 | Topical application of bacteriophages for treatment of wound infections |
Search more.